Breaking News
July 16, 2018 - Advanced Prostate Cancer Variant More Common Than Thought
July 16, 2018 - New ways to conquer sleep apnea compete for place in bedroom
July 16, 2018 - Renowned microbe hunter Stanley Falkow dies at 84 | News Center
July 15, 2018 - FDA Slaps Stronger Warnings on Potent Class of Antibiotics, Fluoroquinolones
July 15, 2018 - Don’t let depression keep you from exercising
July 15, 2018 - Student research symposium showcases curiosity and scholarship | News Center
July 15, 2018 - Heavy smokers have increased risk of heart rhythm disorder, shows study
July 15, 2018 - Parents who had severe trauma, stresses in childhood more likely to have kids with behavioral health problems
July 15, 2018 - At colloquium, a range of views on value of predictive algorithms | News Center
July 15, 2018 - Pittcon invites oral and poster presentations for 2019 Technical Program
July 15, 2018 - Virtual reality could offer psychotherapy for fear of heights, study shows
July 15, 2018 - Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes
July 15, 2018 - Kolon TissueGene To Start US Phase III Clinical Trial For Invossa
July 15, 2018 - Study finds prenatal marijuana use can affect infant size, behavior
July 15, 2018 - Howard Chang named HHMI investigator | News Center
July 15, 2018 - Study shows tailored mental health services improve wellbeing of emerging adults
July 15, 2018 - A bright future might help teens steer clear of violence
July 15, 2018 - Stanford Medicine magazine explores the art, science of listening and hearing | News Center
July 15, 2018 - New study tracks how the brain turns simple sensory inputs into meaningful categories
July 15, 2018 - Deadlier subtype of metastatic prostate cancer found to be common than previously thought
July 15, 2018 - UZH scientists identify enzyme that controls cell division
July 15, 2018 - Unhealthy Food Behaviors May Signal Eating Disorder in Teen
July 15, 2018 - Study raises doubts on a previous theory of Parkinson’s disease
July 15, 2018 - Grant awarded to study whether stem cells can treat urinary incontinence | News Center
July 15, 2018 - Imaging techniques may help assess immune system recovery in HIV patients
July 15, 2018 - Machine-learning may aid in diagnosis and treatment of mental health disorders
July 15, 2018 - ‘Skin Cancer, Take A Hike!’ program promotes sun safety and skin cancer awareness
July 15, 2018 - Blink Health announces lowest prices for generic prescriptions through Blue Eagle Health
July 15, 2018 - New drug strategy can alleviate multiple behavioral, cellular deficiencies in FXS mouse model
July 15, 2018 - Georgia State professor receives federal grant to study virus similar to Ebola virus
July 15, 2018 - Quitting Smoking? Even a Little Exercise Can Help You Stay Slim
July 15, 2018 - DBS treatment may slow the progression of Parkinson’s tremor in early-stage patients
July 15, 2018 - 5 Questions: Luby on virus with potential to cause global pandemic | News Center
July 15, 2018 - Corn loses its cancer-fighting phenolic acids when processed into cornflakes
July 15, 2018 - Study uncovers possible link between iron loading, alcohol intake and mortality
July 15, 2018 - Molecular insights of NagA enzyme could help combat TB
July 15, 2018 - The Facts on Tampons—and How to Use Them Safely
July 15, 2018 - Normalisation of ‘plus-size’ risks hidden danger of obesity, study finds
July 15, 2018 - $2.5 million award to support physician-scientist training | News Center
July 15, 2018 - Aeras announces publication of Phase 2 results of two TB vaccines
July 15, 2018 - Public to set research priorities in field of ethnic inequalities and severe mental illness
July 15, 2018 - Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months
July 15, 2018 - U.S. obesity rates rising again
July 15, 2018 - Millions could have incorrect statin, aspirin and blood pressure prescriptions | News Center
July 15, 2018 - Researchers identify factors associated with cell phone-related distracted driving in parents
July 15, 2018 - Bioethicists suggest ethical considerations for forensic use of genetic data
July 15, 2018 - Most clinical trial participants find benefits of sharing personal data outweigh risks, Stanford study finds | News Center
July 14, 2018 - Researchers solve protein puzzle that paves way for new cancer therapies
July 14, 2018 - Blood telomeres can help predict risk of disease worsening or death in COPD patients
July 14, 2018 - CDC: Nearly One-Third of Injury Deaths Occur at Home
July 14, 2018 - Injectable electronics offer powerful new tool in understanding how retinal cells work
July 14, 2018 - Human blood cells transformed into functional neurons | News Center
July 14, 2018 - Podcast: KHN’s ‘What the Health?’ ACA under fire. Again.
July 14, 2018 - Small device with motion sensors can predict older adults’ risk of falling
July 14, 2018 - Neurological Fallout From Ebola Infection Worse Than Thought
July 14, 2018 - Screening for impaired vision in older adults: New Canadian guideline
July 14, 2018 - Blood test for pregnant women can predict premature birth, Stanford-led study reports | News Center
July 14, 2018 - Study uncovers process that neutralizes tumor cells
July 14, 2018 - Four-protein biomarker blood test improves lung cancer risk assessment for smokers
July 14, 2018 - Researchers develop novel approach to bridge gap in cell-free systems
July 14, 2018 - Research reveals new gears in the circadian clock
July 14, 2018 - Researchers assess role of physician in preventing intimate partner violence perpetration
July 14, 2018 - Two diabetes medications don’t slow progression of type 2 diabetes in youth
July 14, 2018 - New clues to restoring fertility in women with disabling ovary disorder
July 14, 2018 - Compound in citrus oil could reduce dry mouth in head, neck cancer patients | News Center
July 14, 2018 - Streck ARM-D Kits detect more antibiotic resistance than comparable tests
July 14, 2018 - Study finds wide variations in follow-up imaging for women with non-metastatic breast cancer
July 14, 2018 - FDA expands its support for states to implement FSMA Produce Safety Rule
July 14, 2018 - CTI BioPharma Announces the Continuation without Modification of PAC203 Phase 2 Study of Pacritinib in Patients with Myelofibrosis Previously Treated with Ruxolitinib
July 14, 2018 - First-hand accounts of premature baby loss inspires new resource
July 14, 2018 - Study identifies cellular ‘death code’ | News Center
July 14, 2018 - Federal judge enters consent decree against Minnesota dairy farm for selling adulterated meat
July 14, 2018 - New web-based game motivates people to exercise more
July 14, 2018 - Calcium electrotransfer could be used to target cancer cells, study finds
July 14, 2018 - Researchers identify new region in mouse brain that affects appetite and body weight
July 14, 2018 - Repeated testing produces ‘practice effect’ that obscures true cognitive decline
July 14, 2018 - Amgen And UCB Resubmit Biologics License Application (BLA) For Evenity (romosozumab) To The US FDA
July 14, 2018 - New research detects brain cell that improves learning
July 14, 2018 - Spirit, Inspiring Change award winners announced | News Center
July 14, 2018 - Opioid patients face several barriers to treatment, study finds
Clinical trial to test efficacy of stem cell transplants in stopping ALS muscle deterioration

Clinical trial to test efficacy of stem cell transplants in stopping ALS muscle deterioration

image_pdfDownload PDFimage_print

Once funding is obtained, researchers can perform a clinical trial to test the efficacy of transplanting bone marrow cells into muscles to stop deterioration caused by the illness. The method has already yielded positive results on mice.

The Neuroscience Institute at the Universidad Miguel Hernández (UMH) in Elche, Alicante, and the Spanish National Research Council (CSIC) are actively searching for €492,800 to be able to develop a worldwide pioneering test on 100 patients suffering from amyotrophic lateral sclerosis (ALS) which could, by using adult stem cells, stop the progressive deterioration of the locomotor apparatus – which eventually leads to patients’ death. This therapy is spearheaded by the director of the Neuroscience Institute, Salvador Martínez, and has been successfully tested on mice.

The clinical trial would be undertaken over a three year period in the Virgen de la Arrixaca (Murcia), Hospital General (Alicante) and Sant Joan d’Alacant (Alicante) hospitals in eastern Spain and, if successful, would make it possible to then treat, for example, the 900 patients that are diagnosed with ALS every year in Spain, stopping the progressive and inevitable paralysis of their muscles. Neuroscience Institute manager Salvador Martínez has been looking into therapies to fight ALS for two decades, and as the head of a group of a dozen scientists, has been able to verify in a laboratory that transplanting bone marrow cells to the muscles stops the deadly progressive muscular deterioration caused by this illness.

This is possible because adult stem cells from the bone marrow act as guards and prevent the death of motor neurons (named as such because they are in charge of muscle movement), with the added benefit that there is no cell rejection because the transplanted cells are from the same patient. However, a lack of public resources has so far kept testing on humans from being a possibility due to the associated costs. Therefore, the hospitals from Murcia and Alicante have requested a financing project to the Carlos III Health Institute in Madrid, the national entity which covers clinical trials with no commercial purpose.

The objective is to test the transplant of bone marrow cells in the tibialis anterior muscle (located near the shin and which dorsiflexes, or lifts, the foot) as well as in the hand muscles, where the loss of strength due to the illness if clinically very noticeable. The trial would be double-blind and would consist of inoculating the muscles of one hand with bone marrow cells and those in the other with a placebo, without the doctor or the patient knowing which is which.

Once the financing is covered, the study will have to be verified by Spanish Medicine Agency AEMPS before it can be worked on as a potential therapeutic option, which would then make it possible to test other muscles commonly affected by the disease, such as the diaphragm. Martínez explains that ‘this method of transplant keeps our hopes of being much more effective alive, because we can introduce many cells into a muscle, as many as we need, and the amount of times necessary (depending on the size of the muscle). Furthermore, the transplant is performed without surgery and only requires local anaesthetic.’

He explains that public funds are needed to proceed with this line of research against ALS, as this type of therapy ‘isn’t interesting for pharmaceutical laboratories’ because it uses ‘the patient’s own cells’ instead of marketable products.

As many as 100 patients from anywhere in the country would take part in the trial, as long as they have the green light to be recruited by their neurologist. Once the initial transplant is performed in the Arrixaca hospital, electromyography tests would be performed every three months for at least a year in the Hospital General and the Hospital de Sant Joan d’Alacant in order to objectively measure the evolution of the muscle’s strength and range of movement.

Groups from Italy and Norway have already shown interest in this therapy and have asked the Neuroscience Institute for information in order to perform similar tests in their countries. Basic research has been performed in the Institute, located in the Sant Joan d’Alacant campus of the UMH, and has been financed for years by programs of the Spanish Government, the EU and the Spanish Network for Cellular Treatment (TerCel), as well as donations from trusts such as Diógenes and Rotary Illice.

On average, more than two people are diagnosed with ALS every day in Spain, an illness with no cure which only has low-efficiency palliative care treatment available, as it only prolongs a patient’s life by about six months within a three to five year life expectancy period. A genetic origin has been established for 10% of cases, but it remains unknown for the rest, leading to the appearance of theories related to genetic and environmental predisposing factors.

Source:

Stem cell transplants could stop ALS muscle deterioration

Tagged with:

About author

Related Articles